ArticleObesity surgery2009
Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries(II).
Article in Obesity surgery, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 116 citations in OpenAlex.
- Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Pooled it
- Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences.Obesity surgery · 2021Pooled it
- Bariatric surgery: a systematic review of the clinical and economic evidence.Journal of general internal medicine · 2011Pooled it
- Cost-Effectiveness Analysis of Bariatric Surgery and Pharmacological Treatments for People with Obesity and Type 2 Diabetes Mellitus.Obesity surgery · 2026Article
- Exploring the Generalizability of Foreign Cost-Effectiveness Analysis to Spain Using Data From a Scoping Review of Multinational Studies.PharmacoEconomics · 2026Article
- Effectiveness and efficiency of a special program to reduce the bariatric surgery waiting list at a tertiary hospital.Cirugia espanola · 2021Article
- Article
- Economics and Policy in Bariatric Surgery.Current diabetes reports · 2019Review
- Bariatric Surgery Coverage: a Comprehensive Budget Impact Analysis from a Payer Perspective.Obesity surgery · 2018Article
- Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling.Obesity facts · 2017Article
- Bariatric Surgery can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model.Obesity surgery · 2015Article
- An Intensive Lifestyle Intervention Is an Effective Treatment of Morbid Obesity: The TRAMOMTANA Study-A Two-Year Randomized Controlled Clinical Trial.International journal of endocrinology · 2015Article
- Gastric bypass is a cost-saving procedure: results from a comprehensive Markov model.Obesity surgery · 2013Article
- The cost-effectiveness of laparoscopic adjustable gastric banding in the morbidly obese adult population of Australia.PloS one · 2013Article
- Bariatric surgery: cost-effectiveness and budget impact.Obesity surgery · 2012Review
- High-volume bariatric surgery in a single center: safety, quality, cost-efficacy and teaching aspects in 2,000 consecutive cases.Obesity surgery · 2012Article
- Surgical treatment of type 2 diabetes: the surgeon perspective.Endocrine · 2011Review
- Safety, effectiveness, and cost effectiveness of metabolic surgery in the treatment of type 2 diabetes mellitus.Journal of obesity · 2011Article
- The public health implications of the cost-effectiveness of bariatric surgery for diabetes.Diabetes care · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 6 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to establish a payer-perspective cost-effectiveness and budget impact model of adjustable gastric banding (AGB) and gastric bypass (GBP) vs. conventional treatment (CT) in patients with a body mass index (BMI) > or = 35 kg x m(-2) and type 2 diabetes mellitus (T2DM) in Austria, Italy, and Spain.
methodsA health economics model described in a previous publication was applied to resource utilization and cost data in AGB, GBP, and CT from Austria, Italy, and Spain in 2009.
resultsThe base case time scope is 5 years; the annual discount rate for utilities and costs is 3.5%. In Austria and Italy, both AGB and GBP are cost-saving and are thus dominant in terms of incremental cost-effectiveness ratio compared to CT. In Spain, AGB and GBP yield a moderate cost increase but are cost-effective, assuming a willingness-to-pay threshold of 30,000 euro per quality adjusted life-year. Under worst-case analysis, AGB and GBP remain cost-saving or around breakeven in Austria and Italy and remain cost-effective in Spain.
conclusionIn patients with T2DM and BMI > or = 35 kg x m(-2) at 5-year follow-up vs. CT, AGB and GBP are not only clinically effective and safe but represent satisfactory value for money from a payer perspective in Austria, Italy, and Spain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.